ADL5859 HCl

δ-opioid receptor agonist,selective CAS# 850173-95-4

ADL5859 HCl

Catalog No. BCC1265----Order now to get a substantial discount!

Product Name & Size Price Stock
ADL5859 HCl: 5mg $138 In Stock
ADL5859 HCl: 10mg Please Inquire In Stock
ADL5859 HCl: 20mg Please Inquire Please Inquire
ADL5859 HCl: 50mg Please Inquire Please Inquire
ADL5859 HCl: 100mg Please Inquire Please Inquire
ADL5859 HCl: 200mg Please Inquire Please Inquire
ADL5859 HCl: 500mg Please Inquire Please Inquire
ADL5859 HCl: 1000mg Please Inquire Please Inquire
Related Products

Quality Control of ADL5859 HCl

Number of papers citing our products

Chemical structure

ADL5859 HCl

3D structure

Chemical Properties of ADL5859 HCl

Cas No. 850173-95-4 SDF Download SDF
PubChem ID 46931003 Appearance Powder
Formula C24H29ClN2O3 M.Wt 428.95
Type of Compound N/A Storage Desiccate at -20°C
Solubility DMSO : ≥ 100 mg/mL (233.13 mM)
*"≥" means soluble, but saturation unknown.
Chemical Name N,N-diethyl-4-(5-hydroxyspiro[chromene-2,4'-piperidine]-4-yl)benzamide;hydrochloride
SMILES CCN(CC)C(=O)C1=CC=C(C=C1)C2=CC3(CCNCC3)OC4=C2C(=CC=C4)O.Cl
Standard InChIKey ZFNLSWREIULTDO-UHFFFAOYSA-N
Standard InChI InChI=1S/C24H28N2O3.ClH/c1-3-26(4-2)23(28)18-10-8-17(9-11-18)19-16-24(12-14-25-15-13-24)29-21-7-5-6-20(27)22(19)21;/h5-11,16,25,27H,3-4,12-15H2,1-2H3;1H
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of ADL5859 HCl

DescriptionADL5859 HCl is a selective agonist of δ-opioid receptor with Ki value of 0.84 nM.
Targetsδ-opioid receptor    
IC500.84 nM (Ki)     

ADL5859 HCl Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

ADL5859 HCl Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of ADL5859 HCl

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 2.3313 mL 11.6564 mL 23.3127 mL 46.6255 mL 58.2819 mL
5 mM 0.4663 mL 2.3313 mL 4.6625 mL 9.3251 mL 11.6564 mL
10 mM 0.2331 mL 1.1656 mL 2.3313 mL 4.6625 mL 5.8282 mL
50 mM 0.0466 mL 0.2331 mL 0.4663 mL 0.9325 mL 1.1656 mL
100 mM 0.0233 mL 0.1166 mL 0.2331 mL 0.4663 mL 0.5828 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on ADL5859 HCl

Selective δ opioid receptor agonists are promising potential therapeutic agents for the treatment of various types of pain conditions. A spirocyclic derivative was identified as a promising hit through screening. ADL5859 is a potent, selective, and orally bioavailable δ opioid receptor agonist.
In vitro: ADL5859 displayed subnanomolar binding affinity at the δ opioid receptor, potent δ agonist activity, and excellent opioid receptor selectivity. Moreover, ADL5859 showed weak inhibitory activity at the hERG channel (78 μM) [1].
In vivo: On the basis of its favorable profile in vitro, ADL5859 was tested in the rat Freund’s complete adjuvant (FCA) mechanical hyperalgesia assay. At the screening dose of 3 mg/kg po, ADL5859 produced 100% reversal of hyperalgesia in the inflamed paw. The oral ED50 of ADL5859 in the FCA mechanical hyperalgesia assay was 1.4 mg/kg. The antihyperalgesia produced by ADL5859 (3 mg/kg, po) was reversed by pretreatment with the δ opioid antagonist naltrindole (0.3 mg/kg sc), thus demonstrating a δ receptor mediated effect. Therefore, ADL5859 was selected as a clinical candidate for the treatment of pain [1].
Clinical trial: A clinical study has been conducted to investigate the efficacy and safety of ADL5859 and ADL5747 in participants with pain due to osteoarthritis of the knee, which was supposed to be finished in the middle of 2015.
Reference:
[1] Le Bourdonnec B, Windh RT, Ajello CW, Leister LK, Gu M, Chu GH, Tuthill PA, Barker WM, Koblish M, Wiant DD, Graczyk TM, Belanger S, Cassel JA, Feschenko MS, Brogdon BL, Smith SA, Christ DD, Derelanko MJ, Kutz S, Little PJ, DeHaven RN, DeHaven-Hudkins DL, Dolle RE. Potent, orally bioavailable delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-4-(5-hydroxyspiro[chromene-2,4'-piperidine]-4-yl)benzamide (ADL5859). J Med Chem. 2008;51(19):5893-6.

Featured Products
New Products
 

Description

ADL5859 is a δ-opioid receptor agonist with Ki of 0.8 nM, selectivity against opioid receptor κ, μ, and weak inhibitory activity at the hERG channel.

Keywords:

ADL5859 HCl,850173-95-4,Natural Products,Opioid Receptor, buy ADL5859 HCl , ADL5859 HCl supplier , purchase ADL5859 HCl , ADL5859 HCl cost , ADL5859 HCl manufacturer , order ADL5859 HCl , high purity ADL5859 HCl

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: